These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38058118)

  • 1. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
    Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
    Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
    Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
    Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.
    Lee YK; Park NH; Lee H
    Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
    Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
    Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Bidzinski M; Kowalska M
    Tumour Biol; 2016 Jan; 37(1):1271-8. PubMed ID: 26289850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.
    Matsuo K; Takazawa Y; Ross MS; Elishaev E; Podzielinski I; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Matsuzaki S; Baba T; Satoh S; Shida M; Nishikawa T; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Fujiwara K; Hazama Y; Kadogami D; Moffitt MN; Takeuchi S; Nishimura M; Iwasaki K; Ushioda N; Johnson MS; Yoshida M; Hakam A; Li SW; Richmond AM; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Yamaguchi K; Oishi T; Kajiwara H; Hasegawa K; Yasuda M; Kawana K; Suda K; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Wakatsuki A; Sugiyama T; Pejovic T; Nagano T; Shimoya K; Andoh M; Shiki Y; Enomoto T; Sasaki T; Fujiwara K; Mikami M; Shimada M; Konishi I; Kimura T; Post MD; Shahzad MM; Im DD; Yoshida H; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
    Ann Oncol; 2016 Jul; 27(7):1257-66. PubMed ID: 27052653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
    Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
    Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
    Etoh T; Nakai H
    J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of p53 protein in uterine sarcomas.
    Nordal RR; Kristensen GB; Stenwig AE; Tropé CG; Nesland JM
    Gynecol Oncol; 1998 Jul; 70(1):45-8. PubMed ID: 9698472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis.
    Rutkowski P; Kaminska J; Kowalska M; Ruka W; Steffen J
    Int J Cancer; 2002 Aug; 100(4):463-71. PubMed ID: 12115531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.
    Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
    Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD146 as an adverse prognostic factor in uterine sarcoma.
    Zhou Y; Huang H; Yuan LJ; Xiong Y; Huang X; Lin JX; Zheng M
    Eur J Med Res; 2015 Aug; 20(1):67. PubMed ID: 26293576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas.
    Kim SH; Kim JW; Kim YT; Kim JH; Yoon BS; Ryu HS
    Int J Gynaecol Obstet; 2006 Dec; 95(3):272-7. PubMed ID: 16930603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.